Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.

In pediatric patients with SBS-IF, teduglutide treatment resulted in long-term reductions in PN/IV requirements. The degree of PN/IV volume reduction depended on the duration of teduglutide exposure, underlying bowel anatomy, and demographics.